Related Experiment Video
Updated: Jan 31, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.1K
Atrial fibrillation ablation in heart failure
Sergio Richter1, Luigi Di Biase2, Gerhard Hindricks1
1Department of Electrophysiology, Heart Center, University of Leipzig, Strümpellstr. 39, Leipzig, Germany.
European Heart Journal
|December 19, 2018
Summary
Catheter ablation offers a promising treatment for atrial fibrillation in heart failure patients, supported by growing scientific evidence and evolving techniques. This review examines the current data and future prospects for this intervention.
Area of Science:
- Cardiology
- Electrophysiology
- Heart Failure Management
Background:
- Atrial fibrillation (AF) is a common arrhythmia often coexisting with heart failure (HF).
- The management of AF in HF patients presents unique challenges due to potential adverse effects of antiarrhythmic drugs.
- Catheter ablation has emerged as an alternative therapeutic strategy.
Purpose of the Study:
- To review the scientific rationale and evidence supporting catheter ablation for AF in patients with concurrent HF.
- To contextualize ablation strategies within current clinical practice guidelines.
- To explore novel technologies and future research directions in this field.
Main Methods:
- Systematic review of existing literature on catheter ablation for AF in HF.
- Analysis of clinical trial data and observational studies.
- Evaluation of current expert consensus and practice recommendations.
Main Results:
- Evidence suggests catheter ablation can improve atrial fibrillation burden and potentially enhance cardiac function in select heart failure patients.
- Current guidelines acknowledge ablation as a viable option, particularly when medical management is insufficient or poorly tolerated.
- Emerging technologies aim to improve ablation efficacy and safety.
Conclusions:
- Catheter ablation is an increasingly important therapeutic option for patients with atrial fibrillation and heart failure.
- Further research and technological advancements are needed to optimize outcomes and expand patient selection.
- Personalized treatment strategies integrating ablation into comprehensive heart failure management are crucial.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
920
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
920
01:17Pathophysiology of Heart Failure
3.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
01:27Heart Failure I: Introduction
882
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
882
01:22Heart Failure VI: Adjunct Therapies
336
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
336
03:03Amyloid Fibrils
11.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.9K
01:22Heart Failure Drugs: Diuretics
966
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
966